{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:53:55Z","timestamp":1792011235607,"version":"4.4.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2023-00273615"],"award-info":[{"award-number":["RS-2023-00273615"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ogun Ministry of Education Science and Technology","doi-asserted-by":"publisher","award":["RS-2025-23524114"],"award-info":[{"award-number":["RS-2025-23524114"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ogun Ministry of Education Science and Technology","doi-asserted-by":"publisher","award":["2016R1D1A1B02011142"],"award-info":[{"award-number":["2016R1D1A1B02011142"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ogun Ministry of Education Science and Technology","doi-asserted-by":"publisher","award":["2021R1C1C2004755"],"award-info":[{"award-number":["2021R1C1C2004755"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijbiomac.2026.154021","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:00:40Z","timestamp":1786518040000},"page":"154021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structural basis of \u03b1-synuclein and DJ-1 complex"],"prefix":"10.1016","volume":"379","author":[{"given":"Hyeon Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Woo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Suk","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Bok","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.154021_bb0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and molecular diagnosis of synucleinopathies","volume":"16","author":"Koga","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.852003","article-title":"Alpha-synuclein targeting therapeutics for Parkinson's disease and related synucleinopathies","volume":"13","author":"Menon","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.737195","article-title":"The concept of \u03b1-synuclein strains and how different conformations may explain distinct neurodegenerative disorders","volume":"12","author":"Malfertheiner","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228645","article-title":"The role of \u03b1-synuclein oligomers in Parkinson's disease","volume":"21","author":"Du","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","article-title":"\u0391-Synuclein in the pathophysiology of Alzheimer\u2019s disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/mds.70138","article-title":"Nuclear alpha-Synuclein: mechanisms and implications for Synucleinopathies","volume":"41","author":"Outeiro","year":"2026","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tcb.2025.03.007","article-title":"\u03b1-Synuclein condensation in synaptic vesicle function and synucleinopathies","volume":"36","author":"Li","year":"2026","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/CON.0000000000000309","article-title":"Lewy body dementias: dementia with Lewy bodies and Parkinson disease dementia","volume":"22","author":"Gomperts","year":"2016","journal-title":"Continuum"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-025-08186-8","article-title":"Amyloid-\u03b2 and Tau in Alzheimer's disease: pathogenesis, mechanisms, and interplay","volume":"17","author":"Abdulkhaliq","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41583-020-00416-6","article-title":"Reverse engineering Lewy bodies: how far have we come and how far can we go?","volume":"22","author":"Fares","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u0391-Synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167930","article-title":"The hidden cell-to-cell trail of \u03b1-synuclein aggregates","volume":"435","author":"Neupane","year":"2023","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2007.11.027","article-title":"Secretion of DJ-1 into the serum of patients with Parkinson's disease","volume":"431","author":"Maita","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0075","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/carcin\/bgs002","article-title":"DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC\/ERK\/uPA","volume":"33","author":"He","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0080","doi-asserted-by":"crossref","first-page":"10244","DOI":"10.1073\/pnas.0708518105","article-title":"RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways","volume":"105","author":"Van Der Brug","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bcp.2014.11.012","article-title":"DJ-1 as a human oncogene and potential therapeutic target","volume":"93","author":"Cao","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/683920","article-title":"Neuroprotective function of DJ-1 in Parkinson's disease","volume":"2013","author":"Ariga","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0095","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1080\/07391102.2024.2446660","article-title":"Interaction of \u03b1-synuclein with DJ-1 in homodimer and L166P mutant monomer forms in Parkinson's disease: a molecular dynamics study","volume":"44","author":"Alipour","year":"2026","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0100","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1021\/acs.biochem.2c00581","article-title":"DJ-1 molecular chaperone activity depresses tau aggregation propensity through interaction with monomers","volume":"62","author":"Jimenez-Harrison","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0105","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00018-016-2351-6","article-title":"Back to the tubule: microtubule dynamics in Parkinson's disease","volume":"74","author":"Pellegrini","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00308","article-title":"DJ-1 inhibits \u03b1-synuclein aggregation by regulating chaperone-mediated autophagy","volume":"9","author":"Xu","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1083\/jcb.200904103","article-title":"BAG1 restores formation of functional DJ-1 L166P dimers and DJ-1 chaperone activity","volume":"188","author":"Deeg","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0020362","article-title":"DJ-1 is a redox-dependent molecular chaperone that inhibits \u03b1-synuclein aggregate formation","volume":"2","author":"Shendelman","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/cph4.70182","article-title":"Redox regulation and mitochondrial neuroprotection in ischemic stroke: the emerging role of DJ-1 (PARK7)","volume":"16","author":"Ganamurali","year":"2026","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0130","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1471-4159.2005.03145.x","article-title":"DJ-1 is present in a large molecular complex in human brain tissue and interacts with \u03b1-synuclein","volume":"93","author":"Meulener","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ana.10782","article-title":"DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia","volume":"55","author":"Rizzu","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0140","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1134\/S000629792106002X","article-title":"DJ-1 protein and its role in the development of Parkinson's disease: studies on experimental models","volume":"86","author":"Buneeva","year":"2021","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/antiox15010073","article-title":"Oxidative stress and lysosomal dysfunction in neurodegenerative diseases: underlying mechanisms and nanotherapeutic targeting strategies","volume":"15","author":"Hu","year":"2026","journal-title":"Antioxidants"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0155","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.mcn.2004.06.014","article-title":"Dimerization of Parkinson's disease-causing DJ-1 and formation of high molecular weight complexes in human brain","volume":"27","author":"Baulac","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0160","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jmb.2005.12.030","article-title":"The oxidation state of DJ-1 regulates its chaperone activity toward \u03b1-synuclein","volume":"356","author":"Zhou","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0165","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/S0140-6736(26)00865-2","article-title":"Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study","volume":"407","author":"Nikolcheva","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of prasinezumab in early-stage Parkinson's disease","volume":"387","author":"Pagano","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0175","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa2203395","article-title":"Trial of cinpanemab in early Parkinson's disease","volume":"387","author":"Lang","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0180","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1474-4422(20)30136-8","article-title":"Safety and immunogenicity of the \u03b1-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial","volume":"19","author":"Volc","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00415-024-12770-x","article-title":"An update on immune-based alpha-synuclein trials in Parkinson's disease","volume":"272","author":"Alfaidi","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/d41573-022-00212-0","article-title":"LRRK2-targeted Parkinson disease drug advances into phase III","volume":"22","author":"Kingwell","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101466","article-title":"DJ-1 acts as a scavenger of \u03b1-synuclein oligomers and restores monomeric glycated \u03b1-synuclein","volume":"11","author":"Atieh","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118088","article-title":"Cryo-EM structure of HMGB1-RAGE complex and its inhibitory effect on lung cancer","volume":"187","author":"Kim","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149728","article-title":"Cryo-EM structure of influenza a virus NS1 and antiviral protein kinase PKR complex","volume":"706","author":"Kim","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2023.04.107","article-title":"Structural study of novel vaccinia virus E3L and dsRNA-dependent protein kinase complex","volume":"665","author":"Kim","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0215","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1107\/S0907444903008126","article-title":"A graphical user interface to the CCP4 program suite","volume":"59","author":"Potterton","year":"2003","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/1735-1995.181989","article-title":"Alpha-synuclein structure, functions, and interactions","volume":"21","author":"Emamzadeh","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0225","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/s41598-018-20320-5","article-title":"Molecular role of Ca2+ and hard divalent metal cations on accelerated fibrillation and interfibrillar aggregation of \u03b1-synuclein","volume":"8","author":"Han","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0230","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1021\/bi034938r","article-title":"Role of protein-water interactions and electrostatics in \u03b1-synuclein fibril formation","volume":"43","author":"Munishkina","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0235","series-title":"Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease","first-page":"109","article-title":"\u03b1-Synuclein aggregation and modulating factors","author":"Paleologou","year":"2012"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0240","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/B978-0-12-819410-2.00008-4","article-title":"Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease","volume":"184","author":"Marino","year":"2022","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0245","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0304-3940(02)00016-2","article-title":"Human \u03b1-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine","volume":"320","author":"Junn","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0250","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1074\/jbc.M010907200","article-title":"Evidence for a partially folded intermediate in \u03b1-synuclein fibril formation","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jmb.2005.10.071","article-title":"Secondary structure of \u03b1-synuclein oligomers: characterization by Raman and atomic force microscopy","volume":"355","author":"Apetri","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/srep24526","article-title":"Structural and functional properties of prefibrillar \u03b1-synuclein oligomers","volume":"6","author":"Pieri","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0265","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1471-4159.2009.06324.x","article-title":"Seeding induced by \u03b1-synuclein oligomers provides evidence for spreading of \u03b1-synuclein pathology","volume":"111","author":"Danzer","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0270","doi-asserted-by":"crossref","first-page":"31372","DOI":"10.1074\/jbc.M304221200","article-title":"Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease","volume":"278","author":"Tao","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0275","doi-asserted-by":"crossref","first-page":"14079","DOI":"10.1073\/pnas.260503597","article-title":"Crystal structure of an intracellular protease from Pyrococcus horikoshii at 2 \u00c5 resolution","volume":"97","author":"Du","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0280","doi-asserted-by":"crossref","first-page":"44552","DOI":"10.1074\/jbc.M304517200","article-title":"Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain","volume":"278","author":"Lee","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0285","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/S10059-012-2220-6","article-title":"Dissection of the dimerization modes in the DJ-1 superfamily","volume":"33","author":"Jung","year":"2012","journal-title":"Mol. Cells"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0290","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1073\/pnas.0308089100","article-title":"The 1.8 \u00c5 resolution crystal structure of YDR533Cp from Saccharomyces cerevisiae: a member of the DJ-1\/ThiJ\/PfpI superfamily","volume":"101","author":"Wilson","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2026.154021_bb0295","doi-asserted-by":"crossref","first-page":"D253","DOI":"10.1093\/nar\/gkl746","article-title":"SISYPHUS\u2014structural alignments for proteins with non-trivial relationships","volume":"35","author":"Andreeva","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0300","doi-asserted-by":"crossref","first-page":"34069","DOI":"10.1074\/jbc.M804243200","article-title":"Crystal structure of filamentous aggregates of human DJ-1 formed in an inorganic phosphate-dependent manner","volume":"283","author":"Cha","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0305","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/brain\/awad150","article-title":"Advances in understanding the function of alpha-synuclein: implications for Parkinson's disease","volume":"146","author":"Calabresi","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0310","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0315","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.4103\/NRR.NRR-D-25-00274","article-title":"Neurodegenerative diseases and immune system: from pathogenic mechanism to therapy","volume":"21","author":"Chen","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0320","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/138920308785915218","article-title":"\u03b1-Synuclein misfolding and neurodegenerative diseases","volume":"9","author":"Uversky","year":"2008","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0325","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4103\/NRR.NRR-D-25-00648","article-title":"Neurotoxicity, \u03b1-synuclein pathology, and mitochondrial dysfunction: a comparative study of different mouse models of Parkinson's disease","volume":"21","author":"Tang","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0330","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JPD-150543","article-title":"Role of different alpha-synuclein strains in synucleinopathies, similarities with other neurodegenerative diseases","volume":"5","author":"Melki","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0335","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","article-title":"Alpha-synuclein and neurodegenerative diseases","volume":"2","author":"Goedert","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-45589-9","article-title":"Cerebellar oligodendrocytic \u03b1-synuclein pathology and dentate nucleus neuronal hypertrophy in Parkinson's disease","author":"Iacono","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0345","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.freeradbiomed.2009.08.003","article-title":"DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders","volume":"47","author":"Kahle","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0350","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.embor.7400074","article-title":"DJ-1 has a role in antioxidative stress to prevent cell death","volume":"5","author":"Taira","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci15090899","article-title":"Interaction between \u03b1-synuclein and DJ-1 in Parkinson's disease","volume":"15","author":"Sobhifar","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0360","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-026-05981-y","article-title":"DJ-1 in the neuro-cutaneous aging axis: unifying pathways of Parkinson's disease neurodegeneration, progression, and redox-based therapeutic strategies for healthy longevity","volume":"63","author":"Sivalingam","year":"2026","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0365","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/1567204043396622","article-title":"Strategies to improve stability and bioavailability of peptide drugs","volume":"1","author":"Adessi","year":"2004","journal-title":"Frontiers in Medicinal Chemistry - Online"},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0370","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jmr.699","article-title":"The effect of macromolecular crowding on protein aggregation and amyloid fibril formation","volume":"17","author":"Munishkina","year":"2004","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.ijbiomac.2026.154021_bb0375","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of \u03b1-synuclein is regulated by fatty acids and enhanced in Parkinson's disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302603967X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302603967X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:41:04Z","timestamp":1792010464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302603967X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":75,"alternative-id":["S014181302603967X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154021","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural basis of \u03b1-synuclein and DJ-1 complex","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154021"}}